A Phase IV, Open-Label, Single-Arm Study of Prophylaxis for Datopotamab Deruxtecan-related Stomatitis in Eligible Patients with Metastatic or Inoperable Locally Recurrent Breast Cancer or
Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer (TROPION-SWISH)
The Metro-Minnesota Community Oncology Research Consortium (MMCORC) is a nonprofit research program sponsored by the National Cancer Institute (NCI) and participating hospitals and clinics. Local physician have access to the newest advances in cancer research. The MMCORC links community cancer specialists, primary care physicians and other health care professionals to NCI-approved research studies, called clinical trials.
The NCI Community Oncology Research Program (NCORP) brings cancer research studies and results to patients in a variety of community settings across the United States. 7 Research Bases Develop and coordinate clinical trials and cancer care research for 32 Community Sites and 14 Minority/Underserved Community Sites to bring NCI approved trials to patients including 1,000+ locations at diverse, community-based hospitals, private practices and more.
© 2026 Metro Minnesota Community Oncology Research Consortium.